Covance Opens Fit-for-Purpose Dallas Clinical Research Unit

LabCorp patient service center to be co-located in new facility to serve local patients and enhance volunteer recruitment DALLAS --(BUSINESS WIRE)--Jul. 23, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that Covance Drug Development has relocated its

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp Expands Access to LabCorp AccuDraw® to Support Better Patient Care

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 4, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (LH: NYSE) today announced the expanded availability of its proprietary specimen collection and handling software, LabCorp Accu Draw ® , to all clients through its website at www.LabCorp.com

LabCorp is Scheduled to Present at the Goldman Sachs 36th Annual Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 2, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced it will participate at the Goldman Sachs 36 th Annual Global Healthcare Conference. LabCorp’s presentation is planned for Tuesday, June 9, 2015 at 5:00 PM (ET) .

Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology

KOBE, Japan & BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 1, 2015-- Sysmex Corporation (TSE:6869) and Laboratory Corporation of America ® Holdings (LabCorp ® ) (LH:NYSE) today announced a strategic collaboration focused on the development of blood-based molecular diagnostic tests to advance precision

LabCorp Announces Full Portfolio of Hepatitis C Virus Drug Resistance Assays

Expanded testing services enable precision medicine by providing clinicians with information to select optimal treatment and characterize treatment failure BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the

LabCorp is Scheduled to Present at the UBS Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced it will participate at the UBS Global Healthcare Conference . LabCorp’s presentation is planned for Tuesday, May 19, 2015 at 8:00 AM (ET) .

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 6, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced it will participate at the Bank of America Merrill Lynch 2015 Health Care Conference . LabCorp’s presentation is planned for Thursday, May 14, 2015 at 11:40 AM (ET)

Laboratory Corporation of America® Holdings Announces 2015 First Quarter Results and Raises 2015 Adjusted EPS Guidance

Q1 Net revenue of $1.8 billion , up 24% over last year Q1 Diluted EPS of $0.01 ; Q1 Adjusted EPS of $1.73 , up 15% over last year 2015 Adjusted EPS guidance raised to $7.55 - $7.90 , compared to $6.80 in 2014 BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 27, 2015-- Laboratory Corporation of America ®

Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers

BRCA Share™ is a novel public-private initiative designed to enhance the clarity and quality of patient testing MADISON, N.J. and PARIS and BURLINGTON, N.C. , April 21, 2015 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Inserm,